Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH for Growth Failure in Pediatric CKD
NCT00194961Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Growth failure (FTT), sponsored by Weill Cornell Medicine. Primary endpoint: Biochemical/Metabolic and Immunologic Parameters in Relation to Body Composition at 6 months. Status: terminated.
02
Drugs
somatropin
03
Conditions
Growth failure (FTT)
Beyond the preview
Go deeper on NCT00194961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194961.